Centers for Disease Control and Prevention, Atlanta, GA 30341, USA.
Contraception. 2010 Jul;82(1):41-55. doi: 10.1016/j.contraception.2010.02.011. Epub 2010 Mar 29.
There are concerns that intrauterine device (IUD) use by women with uterine fibroids might increase their uterine bleeding or risk for device expulsion. The objective of this systematic review was to evaluate evidence concerning the safety and effectiveness of IUD use among women with uterine fibroids. Key questions included whether IUD use is associated with increased risk for uterine bleeding among women with uterine fibroids and whether the presence of uterine fibroids is associated with an increased risk for device expulsion among IUD users.
We searched the PubMed database for peer-reviewed articles relevant to IUD (copper or levonorgestrel-releasing) use and uterine fibroids published in any language from database inception through June 2009. We used standard abstract forms and a grading system to summarize and assess the quality of the evidence.
From 202 articles found in the database search, we identified 11 studies that met our inclusion criteria, all of which examined outcomes among users of the levonorgestrel-releasing IUD (LNG-IUD). Evidence from 10 of 11 noncomparative studies (Level II-3, fair) suggests that LNG-IUD use among women with fibroids does not increase menstrual bleeding, and results from all 11 showed that menstrual blood loss decreased among women who continued to use the LNG-IUD through the end of the study period. Overall, serum levels of hemoglobin, hematocrit and ferritin increased among LNG-IUD users in studies that assessed these outcomes. Several studies reported some occurrences of irregular bleeding. Findings from two cohort studies (Level II-2, fair to poor) showed rates of LNG-IUD expulsion to be higher among women with uterine fibroids (11% in each) than among women without uterine fibroids (0% and 3%); however, in one study the difference was not statistically significant, and in the other significance testing was not conducted. Six prospective noncomparative studies reported expulsion rates of 0-20% among women with uterine fibroids.
Most women with uterine fibroids are likely to have less menstrual blood loss and higher serum levels of hemoglobin, hematocrit and ferritin after insertion of an LNG-IUD, despite some occurrences of irregular bleeding. LNG-IUD users with uterine fibroids may have higher rates of expulsion than those without fibroids.
有人担心,子宫肌瘤患者使用宫内节育器(IUD)会增加其子宫出血或器械脱落的风险。本系统评价的目的是评估子宫肌瘤患者使用宫内节育器的安全性和有效性的证据。关键问题包括子宫肌瘤患者使用宫内节育器是否与出血风险增加有关,以及子宫肌瘤患者使用宫内节育器是否与器械脱落风险增加有关。
我们在 PubMed 数据库中搜索了以任何语言发表的、与宫内节育器(铜或左炔诺孕酮释放)使用和子宫肌瘤相关的、从数据库建立至 2009 年 6 月的同行评审文章。我们使用标准摘要表格和评分系统来总结和评估证据的质量。
从数据库搜索中发现的 202 篇文章中,我们确定了 11 项符合纳入标准的研究,这些研究均考察了左炔诺孕酮释放宫内节育器(LNG-IUD)使用者的结局。11 项非比较性研究中的 10 项(II-3 级,中等质量)的证据表明,肌瘤患者使用 LNG-IUD 不会增加月经出血,而所有 11 项研究均表明,在研究期间继续使用 LNG-IUD 的女性的月经失血量减少。总的来说,在评估这些结局的研究中,LNG-IUD 使用者的血清血红蛋白、血细胞比容和铁蛋白水平升高。一些研究报告了不规则出血的一些发生情况。两项队列研究(II-2 级,中等至较差质量)的结果显示,子宫肌瘤患者的 LNG-IUD 脱落率(各 11%)高于无子宫肌瘤患者(各 0%和 3%);然而,一项研究中的差异无统计学意义,另一项研究未进行统计学检验。六项前瞻性非比较性研究报告了子宫肌瘤患者的脱落率为 0-20%。
尽管存在一些不规则出血的情况,但大多数患有子宫肌瘤的女性在放置 LNG-IUD 后可能会出现经量减少和更高的血清血红蛋白、血细胞比容和铁蛋白水平。患有子宫肌瘤的 LNG-IUD 使用者的脱落率可能高于无肌瘤者。